Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Medical School to Serve as Exiqon MicroRNA Center of Excellence

NEW YORK (GenomeWeb News) – Scientists at Harvard Medical School and its related institutions will use Exiqon's Locked Nucleic Acid microRNA Knockdown Library for high-throughput screening of small molecule and RNAi libraries, the Danish company said today.

Under the agreement, Harvard's ICCB-Longwood Screening Facility will serve as a microRNA Screening Center of Excellence, enabling it to provide the Exiqon technology to a new consortium of investigators at and affiliated with Harvard.

The Knockdown Library contains more than 900 specific inhibitors, and it incorporates Exiqon's LNA detection technology.

"There is a great deal of interest in our community in using miRNA knockdown reagents to study disease-related biology," Neil Kubica, a research fellow in cell biology at Harvard Medical School and the consortium's coordinator, said in a statement.

Financial terms of the agreement were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.